Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Tam

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Antibody Therapeutics|October 27, 2022
Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammationRuth Bone, Brian J Fennell, Amy Tam, et al.
Mabs|June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and BMacy Jin, Sunita Hett, Reema Jasuja, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2023
Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4-Related Hereditary Spastic ParaplegiaJulian E Alecu, Afshin Saffari, Marvin Ziegler, et al.
Mabs|June 4, 2026
Generation of human sequence antibodies in OmniChicken against the highly conserved mammalian target BDNF using three distinct discovery workflowsKathryn H Ching, Sinéad Keating, Baisen Zeng, et al.
Annals of Clinical and Translational Neurology|May 7, 2024
The spectrum of movement disorders in young children with ARX-related epilepsy-dyskinesia syndromeShyam K Akula, Vicente Quiroz, Alissa M D'Gama, et al.
Biotechnology Progress|April 23, 2021
Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific moleculeBarbara Tevelev, Himakshi Patel, Kathleen Shields, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 9, 2025
Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 (HSP-SPG11) and Type 15 (HSP-ZFYVE26)Habibah A P Agianda, Julian E Alecu, Amy Tam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 2, 2025
Spectrum of Movement Disorders in Early-Onset Hereditary Spastic Paraplegia: A Study of 428 CasesDario Resch, Julian E Alecu, Kathryn Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2024
Recommendations for the Management of Initial and Refractory Pediatric Status DystonicusLindsey M Vogt, Kathryn Yang, Gabriel Tse, et al.
The AAPS Journal|April 26, 2017
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug ConjugatesL Nathan Tumey, Fengping Li, Brian Rago, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Antibody Therapeutics|October 27, 2022
Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammationRuth Bone, Brian J Fennell, Amy Tam, et al.
Mabs|June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and BMacy Jin, Sunita Hett, Reema Jasuja, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2023
Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4-Related Hereditary Spastic ParaplegiaJulian E Alecu, Afshin Saffari, Marvin Ziegler, et al.
Mabs|June 4, 2026
Generation of human sequence antibodies in OmniChicken against the highly conserved mammalian target BDNF using three distinct discovery workflowsKathryn H Ching, Sinéad Keating, Baisen Zeng, et al.
Annals of Clinical and Translational Neurology|May 7, 2024
The spectrum of movement disorders in young children with ARX-related epilepsy-dyskinesia syndromeShyam K Akula, Vicente Quiroz, Alissa M D'Gama, et al.
Biotechnology Progress|April 23, 2021
Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific moleculeBarbara Tevelev, Himakshi Patel, Kathleen Shields, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 9, 2025
Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 (HSP-SPG11) and Type 15 (HSP-ZFYVE26)Habibah A P Agianda, Julian E Alecu, Amy Tam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 2, 2025
Spectrum of Movement Disorders in Early-Onset Hereditary Spastic Paraplegia: A Study of 428 CasesDario Resch, Julian E Alecu, Kathryn Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2024
Recommendations for the Management of Initial and Refractory Pediatric Status DystonicusLindsey M Vogt, Kathryn Yang, Gabriel Tse, et al.
The AAPS Journal|April 26, 2017
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug ConjugatesL Nathan Tumey, Fengping Li, Brian Rago, et al.
Pageof 5